Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes

Fibrogenesis and Tissue Repair

Volumn 3, Issue 1, 2010, Pages

  Courneya, Jean Paul ^a   Luzina, Irina G ^b   Zeller, Cynthia B ^c   Rasmussen, Jeffrey F ^a,b   Bocharov, Alexander ^b   Schon, Lew C ^a   Atamas, Sergei P ^b  

^a UNION MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c TOWSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2B; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; MESSENGER RNA;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MATRIX ATTACHMENT REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TENDON; TENDON RECONSTRUCTION; TENOCYTE; TISSUE ENGINEERING;

EID: 79955944481     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-3-9     Document Type: Article

References (23)

1. Witvrouw E, Bellemans J, Lysens R, Danneels L, Cambier D. Intrinsic risk factors for the development of patellar tendinitis in an athletic population. A two-year prospective study. Am J Sports Med 2001, 29:190-5.
2. Kujala UM, Sarna S, Kaprio J. Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sports Med 2005, 15:133-5.
3. White DW, Wenke JC, Mosely DS, Mountcastle SB, Basamania CJ. Incidence of major tendon ruptures and anterior cruciate ligament tears in US Army soldiers. Am J Sports Med 2007, 35:1308-14. 10.1177/0363546507301256, 17468380.
4. Owens B, Mountcastle S, White D. Racial differences in tendon rupture incidence. Int J Sports Med 2007, 28:617-20. 10.1055/s-2007-964837, 17357966.
5. Dillon C, Petersen M, Tanaka S. Self-reported hand and wrist arthritis and occupation: data from the U.S. National Health Interview Survey - Occupational Health Supplement. Am J Ind Med 2002, 42:318-27. 10.1002/ajim.10117, 12271479.
6. Tanaka S, Petersen M, Cameron L. Prevalence and risk factors of tendinitis and related disorders of the distal upper extremity among U.S. workers: comparison to carpal tunnel syndrome. Am J Ind Med 2001, 39:328-35. 10.1002/1097-0274(200103)39:3<328::AID-AJIM1021>3.0.CO;2-I, 11241566.
7. Sharma P, Maffulli N. Biology of tendon injury: healing, modeling and remodeling. J Musculoskelet Neuronal Interact 2006, 6:181-90.
8. Shah MK. Outcomes in bilateral and simultaneous quadriceps tendon rupture. Orthopedics 2003, 26:797-8.
9. McQueen F, Beckley V, Crabbe J, Robinson E, Yeoman S, Stewart N. Magnetic resonance imaging evidence of tendinopathy in early rheumatoid arthritis predicts tendon rupture at six years. Arthritis Rheum 2005, 52:744-51. 10.1002/art.20947, 15751075.
10. Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf 2006, 15:784-92. 10.1002/pds.1214, 16456878.
11. Hersh BL, Heath NS. Achilles tendon rupture as a result of oral steroid therapy. J Am Podiatr Med Assoc 2002, 92:355-8.
12. Maffulli N, Wong J, Almekinders L. Types and epidemiology of tendinopathy. Clin Sports Med 2003, 22:675-92. 10.1016/S0278-5919(03)00004-8, 14560540.
13. Fredberg U, Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports 2008, 18:3-15. 10.1111/j.1600-0838.2007.00746.x, 18294189.
14. Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008, 466:1539-54. 10.1007/s11999-008-0260-1, 2505250, 18446422.
15. Shukunami C, Takimoto A, Oro M, Hiraki Y. Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol 2006, 298:234-47. 10.1016/j.ydbio.2006.06.036, 16876153.
16. Atamas SP. Complex cytokine regulation of tissue fibrosis. Life Sci 2002, 72:631-43. 10.1016/S0024-3205(02)02299-3, 12467904.
17. Atamas SP, White B. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev 2003, 14:537-50. 10.1016/S1359-6101(03)00060-1, 14563355.
18. Atamas SP, Luzina IG, Dai H, Wilt SG, White B. Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol 2002, 168:1139-45.
19. Nacu N, Luzina IG, Highsmith K, Lockatell V, Pochetuhen K, Cooper ZA, Todd NW, Atamas SP. Macrophages utilize TGFBI (BIGH3) following ingestion of apoptotic cells to reduce MMP14 levels and collagen turnover in fibroblasts. J Immunol 2008, 180:5036-44. 2847349, 18354229.
20. Lin TW, Cardenas L, Soslowsky LJ. Tendon properties in interleukin-4 and interleukin-6 knockout mice. J Biomech 2005, 38:99-105.
21. Lin TW, Cardenas L, Glaser DL, Soslowsky LJ. Tendon healing in interleukin-4 and interleukin-6 knockout mice. J Biomech 2006, 39:61-9. 10.1016/j.jbiomech.2004.11.009, 16271588.
22. Ricchetti ET, Reddy SC, Ansorge HL, Zgonis MH, Van Kleunen JP, Liechty KW, Soslowsky LJ, Beredjiklian PK. Effect of interleukin-10 overexpression on the properties of healing tendon in a murine patellar tendon model. J Hand Surg Am 2008, 33:1843-52. 10.1016/j.jhsa.2008.07.020, 19084188.
23. John T, Lodka D, Kohl B, Ertel W, Jammrath J, Conrad C, Stoll C, Busch C, Schulze-Tanzil G. Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. J Orthop Res 2010, DOI: 10.1002/jor.21079.